Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO MAP 2022 | Immune cell contexture at the single cell level

Ankur Sharma • 28 Sep 2022
ESMO MAP 2022 MAP 2022
General

Ankur Sharma, PhD, Curtin University, Perth, Australia, provides an overview of his presentation at the Molecular Analysis for Precision oncology (MAP) Congress 2022 on immune cell contexture at the single cell level, involving research on the interaction between immune cells and the tumor microenvironment.This interview took place at the Molecular Analysis for Precision oncology (MAP) Congress 2022 in Amsterdam, Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Ankur Sharma

Tracking tumor evolution for the development of prognostic tools
1:06
Tracking tumor evolution for the development of prognostic tools
Ankur Sharma • 28 Sep 2022
The co-evolution of the tumor and the TME under chemo- and immunotherapeutic selection pressures
1:15
The co-evolution of the tumor and the TME under chemo- and immunotherapeutic selection pressures
Ankur Sharma • 28 Sep 2022
Immunosuppressive onco-fetal reprogramming of the tumor ecosystem
0:40
Immunosuppressive onco-fetal reprogramming of the tumor ecosystem
Ankur Sharma • 28 Sep 2022
The similarities between fetal and tumor microenvironment
1:22
The similarities between fetal and tumor microenvironment
Ankur Sharma • 28 Sep 2022

Related Videos

AI governance and validation in robotic cancer surgery
1:12
AI governance and validation in robotic cancer surgery
Marie Hanaoka • 1 Jul 2026
Does toxicity differ between patients treated with SABR for one versus five lesions?
0:39
Does toxicity differ between patients treated with SABR for one versus five lesions?
Robert Olson • 16 May 2026
5-year toxicity following SABR: insights from the SABR-5 trial
0:42
5-year toxicity following SABR: insights from the SABR-5 trial
Robert Olson • 16 May 2026
How should results from the SABR-5 trial guide future SABR studies?
1:05
How should results from the SABR-5 trial guide future SABR studies?
Robert Olson • 16 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals